Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy
- PMID: 18329345
- DOI: 10.1016/j.dnarep.2008.01.014
Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy
Abstract
Laboratory diagnosis for DNA repair diseases has been performed in western Europe from the early seventies for xeroderma pigmentosum (XP) and from the mid-eighties for Cockayne syndrome (CS) and trichothiodystrophy (TTD). The combined data from the DNA repair diagnostic centres in France, (West) Germany, Italy, the Netherlands and the United Kingdom have been investigated for three groups of diseases: XP (including XP-variant), CS (including XP/CS complex) and TTD. Incidences in western Europe were for the first time established at 2.3 per million livebirths for XP, 2.7 per million for CS and 1.2 per million for TTD. As immigrant populations were disproportionately represented in the patients' groups, incidences were also established for the autochthonic western European population at: 0.9 per million for XP, 1.8 per million for CS and 1.1 per million for TTD. Perhaps contrary to general conceptions, compared to XP the incidence of CS appears to be somewhat higher and the incidence of TTD to be quite similar in the native West-European population.
Similar articles
-
Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.DNA Repair (Amst). 2008 Dec 1;7(12):1990-8. doi: 10.1016/j.dnarep.2008.08.009. Epub 2008 Oct 10. DNA Repair (Amst). 2008. PMID: 18817897
-
The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.Cancer Res. 2000 Jan 15;60(2):431-8. Cancer Res. 2000. PMID: 10667598
-
Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.Exp Dermatol. 2013 Jul;22(7):486-9. doi: 10.1111/exd.12166. Exp Dermatol. 2013. PMID: 23800062
-
Xeroderma pigmentosum-Cockayne syndrome complex.Orphanet J Rare Dis. 2017 Apr 4;12(1):65. doi: 10.1186/s13023-017-0616-2. Orphanet J Rare Dis. 2017. PMID: 28376890 Free PMC article. Review.
-
A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.Hum Mutat. 1999;14(1):9-22. doi: 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.0.CO;2-6. Hum Mutat. 1999. PMID: 10447254 Review.
Cited by
-
The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care.Genet Med. 2016 May;18(5):483-93. doi: 10.1038/gim.2015.110. Epub 2015 Jul 23. Genet Med. 2016. PMID: 26204423 Free PMC article.
-
Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew.Arch Dermatol. 2009 Nov;145(11):1285-91. doi: 10.1001/archdermatol.2009.279. Arch Dermatol. 2009. PMID: 19917958 Free PMC article.
-
Functional Comparison of XPF Missense Mutations Associated to Multiple DNA Repair Disorders.Genes (Basel). 2019 Jan 17;10(1):60. doi: 10.3390/genes10010060. Genes (Basel). 2019. PMID: 30658521 Free PMC article.
-
Scalp squamous cell carcinoma in xeroderma pigmentosum.N Am J Med Sci. 2014 Feb;6(2):105-6. doi: 10.4103/1947-2714.127754. N Am J Med Sci. 2014. PMID: 24695441 Free PMC article.
-
The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies.Cancers (Basel). 2023 May 10;15(10):2706. doi: 10.3390/cancers15102706. Cancers (Basel). 2023. PMID: 37345043 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
